CAMKK1 associations with appetite‐regulating, metabolic and inflammatory factors were perturbed by T2DM, with preliminary evidence of diverging patterns of alterations within both obesity and T2DM (i.e., attenuated satiety signalling for obesity; strengthened inflammatory elevation for T2DM). This evidence concerns the gene CAMKK1 and obesity disorder.